Model Number AVFM10060 |
Device Problem
Obstruction of Flow (2423)
|
Patient Problems
Pain (1994); Stenosis (2263); Numbness (2415)
|
Event Date 05/31/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
The catalog number identified has not been cleared in the u.S.But, it is similar to the covera vascular covered stent system products that are cleared in the us.The 510 k number and pro code for the pcovera vascular covered stent system products are identified.As the lot number for the device was provided, a manufacturing review will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.(expiry date: 09/2017).
|
|
Event Description
|
It was reported through the results of a clinical trial, approximately 4 months, 4 days post index procedure, 80% stenosis lesion was identified and re-intervention was performed using a standard pta balloon and final residual stenosis was 0%.It was further reported that approximately 4 months, 20 days post index procedure, 60% stenosis lesion was identified and re-intervention was performed using a standard pta balloon and thrombectomy/thrombolysis.Reportedly, approximately 5 months, 17 days post index procedure, 60% stenosis lesion was identified and re-intervention was performed.It was further reported that approximately 1 months, 6 months post index procedure, 50% stenosis lesion was identified and re-intervention was performed using standard pta.
|
|
Manufacturer Narrative
|
H10: manufacturing review: the lot number was provided and a lot history review was performed.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: a physical sample was not available for evaluation, and images have not been provided; the alleged stenosis could not be re produced which led to an inconclusive evaluation result.Based on the information available a definite root cause for the event reported could not be determined.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.
|
|
Event Description
|
It was reported through the results of a clinical trial that approximately four months post index procedure, stenosis in the target lesion was identified and standard pta and thrombectomy were performed.Approximately five months and one year six months post index procedure, target lesion stenosis was identified and re-intervention was performed, including pta.Approximately two years seven months post index procedure, an av fistula aneurysm was identified.The patient was admitted to the hospital and the av fistula was resected and an av graft was placed.The patient completed the study.
|
|
Search Alerts/Recalls
|
|